SJD Barcelona Children’s Hospital
Chemotherapy for brain tumors in Spain typically costs from $8,000 to $16,000. The total price depends on the drug protocol, number of cycles, and clinic location. Patients save about 60% compared to the US, where the average cost is $30,000. Standard billing usually covers oncologist consultations, chemotherapy drugs, nursing care, and pre-treatment bloodwork.
Bookimed Expert Insight: Spain offers elite oncology care at a fraction of US prices. Clinica Universidad de Navarra is the first Spanish hospital JCI-accredited. It currently holds a 5-star patient rating on Bookimed. SJD Barcelona Children's Hospital ranks among the top three European medical institutions. Choosing a center with a multidisciplinary tumor board ensures the most effective drug protocol. This collaborative approach often leads to better value by avoiding unnecessary cycles.
| Turkey | Austria | Spain | |
| Chemotherapy for Brain Tumor | from $1,000 | from $12,000 | from $8,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Chemotherapy for Brain Tumor upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Chemotherapy for Brain Tumor and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Chemotherapy for Brain Tumor journey.
Day 1: Arrival
Day 2-3: Pre-operation
Day 4-5: Chemotherapy for Brain Tumor
Day 6: Post-operation
Week 1-2: Rehabilitation
Week 3: Return to Normal Activities
Week 4: Final Result
Please note that the timeline and process can vary depending on individual circumstances and the specifics of the brain tumor. Always consult with your healthcare team for advice tailored to your situation.
Dr. Graus led the panel defining strict criteria for diagnosing paraneoplastic neurological syndromes – a rare complication of cancer treatment.
The doctor is a highly skilled neurosurgeon specializing in the treatment of brain tumors. With extensive experience in both surgical and non-surgical approaches, the doctor has contributed significantly to advancements in neuro-oncology. The doctor is recognized for implementing cutting-edge techniques and has published numerous research papers in leading medical journals. The doctor is committed to improving patient outcomes through innovative treatment strategies and is actively involved in clinical trials aimed at developing new therapies for brain tumor patients.
The doctor is an experienced oncologist recognized for successful breast cancer treatments. He holds an MBBS from University Autónoma de Barcelona and completed his residency at Clinic Vall d'Hebron. He conducted significant research on telomerase in New York.
He is the head of the breast cancer program at HM Delfos and leads Oncology services at Clin del Mar in Spain. As the director of the cancer research program at Del Mar, he is a prominent member of GEICAM, CIBERONC, AIECA, and SEOM. The doctor has published 120 articles in reputable journals, amassing over 9000 citations.